Design Therapeutics, Inc. (DSGN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$9.93
Day's range
$10.43

Design Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SR ONE CAPITAL MANAGEMENT, LP 05/14/2026 6.53 M $69.44 M   0.00% 11.38%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 2.97 M $31.63 M   103.44% 5.19%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 2.72 M $28.97 M   -49.32% 4.75%
BAKER BROS. ADVISORS LP 05/15/2026 2.59 M $27.51 M   15.80% 4.51%
BLACKROCK, INC. 05/13/2026 2.13 M $22.70 M   0.78% 3.72%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 1.95 M $20.75 M   -22.00% 3.40%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 1.74 M $18.57 M   47.90% 3.04%
VIVO CAPITAL, LLC 05/20/2026 1.61 M $17.16 M   0.00% 2.81%
ALMITAS CAPITAL LLC 05/15/2026 1.53 M $16.28 M   -0.01% 2.67%
05/15/2026 1.35 M $14.36 M   100.00% 2.35%
WOODLINE PARTNERS LP 05/15/2026 961.50 K $10.23 M   1.85% 1.68%
05/15/2026 852.01 K $9.07 M   100.00% 1.49%
FMR LLC 05/15/2026 798.41 K $8.50 M   3.52% 1.39%
KYNAM CAPITAL MANAGEMENT, LP 05/15/2026 784.61 K $8.35 M   0.00% 1.37%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 692.52 K $7.37 M   1.90% 1.21%
STATE STREET CORP 05/15/2026 659.58 K $7.02 M   1.84% 1.15%
MORGAN STANLEY 05/15/2026 656.57 K $6.99 M   -6.51% 1.15%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 616.48 K $6.56 M   0.61% 1.08%
GOLDMAN SACHS GROUP INC 05/15/2026 504.72 K $5.37 M   86.48% 0.88%
D. E. SHAW & CO., INC. 05/15/2026 470.27 K $5.00 M   7.15% 0.82%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 431.84 K $4.59 M   44.95% 0.75%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 408.20 K $4.34 M   42.18% 0.71%
NORTHERN TRUST CORP 05/14/2026 300.28 K $3.19 M   4.78% 0.52%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2026 289.39 K $3.08 M   48.70% 0.50%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 271.55 K $2.89 M   442.86% 0.47%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 241.49 K $2.57 M   1.95% 0.42%
CITADEL ADVISORS LLC 05/15/2026 231.51 K $2.46 M   -49.66% 0.40%
05/15/2026 207.90 K $2.21 M   0.00% 0.36%
ALGERT GLOBAL LLC 05/14/2026 204.74 K $2.18 M   9.04% 0.36%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 195.66 K $2.08 M   100.00% 0.34%
MARSHALL WACE, LLP 05/15/2026 151.01 K $1.61 M   -33.04% 0.26%
ACUTA CAPITAL PARTNERS, LLC 05/15/2026 145.90 K $1.55 M   -3.32% 0.25%
INVESCO LTD. 05/12/2026 141.92 K $1.51 M   -53.58% 0.25%
05/08/2026 138.57 K $1.47 M   100.00% 0.24%
SEI INVESTMENTS CO 05/13/2026 133.20 K $1.42 M   152.61% 0.23%
NUVEEN, LLC 04/30/2026 126.82 K $1.35 M   1.24% 0.22%
LYNX1 CAPITAL MANAGEMENT LP 05/04/2026 119.52 K $1.27 M   71.93% 0.21%
TREXQUANT INVESTMENT LP 05/15/2026 117.11 K $1.25 M   17.15% 0.20%
MILLENNIUM MANAGEMENT LLC 05/15/2026 108.93 K $1.16 M   -39.77% 0.19%
RAYMOND JAMES FINANCIAL INC 05/14/2026 108.45 K $1.15 M   -1.20% 0.19%
JANE STREET GROUP, LLC 05/12/2026 103.90 K $1.11 M   -54.13% 0.18%
VERDAD ADVISERS, LP 05/15/2026 92.31 K $982.18 K   100.00% 0.16%
CAPTION MANAGEMENT, LLC 05/15/2026 86.71 K $922.57 K   100.00% 0.15%
SQUAREPOINT OPS LLC 05/15/2026 86.12 K $916.29 K   86.63% 0.15%
BANK OF NEW YORK MELLON CORP 05/05/2026 79.65 K $847.42 K   -6.27% 0.14%
EAM INVESTORS, LLC 05/13/2026 78.95 K $840.02 K   0.00% 0.14%
PALUMBO WEALTH MANAGEMENT LLC 05/12/2026 71.41 K $759.78 K   2.93% 0.12%
AMERICAN CENTURY COMPANIES INC 05/15/2026 65.64 K $698.39 K   13.56% 0.11%
XTX TOPCO LTD 05/15/2026 60.94 K $648.39 K   72.71% 0.11%
CANADA PENSION PLAN INVESTMENT BOARD 05/15/2026 60.40 K $642.66 K   10.62% 0.11%

Design Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 197 institutional investors and hedge funds held shares of Design Therapeutics Inc. The most heavily invested institutionals were:

SR ONE CAPITAL MANAGEMENT, LP: 6.53 M

RA CAPITAL MANAGEMENT, L.P.: 2.97 M

Point72 Asset Management, L.P.: 2.72 M

BAKER BROS. ADVISORS LP: 2.59 M

BlackRock, Inc.: 2.13 M

Logos Global Management LP: 1.95 M

66.26% of Design Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 46.61 M shares in the last 24 months. This purchase volume represents approximately $483.35 M in transactions.